Finlay Institute
From Wikipedia, the free encyclopedia
The Finlay Institute (Spanish: Instituto Finlay de Vacunas, lit. 'Finlay Vaccine Institute') is a Cuban organization that carries out medical research and mainly produces vaccines. It is named after the Cuban doctor Carlos Finlay, who was the first to hypothesize the involvement of a mosquito as a vector of yellow fever.[2]
 | This article relies largely or entirely on a single source. (July 2021) |
 | |
| Established | 1991 |
|---|---|
| Staff | 970 (2014)[1] |
| Address | Avenida 21 No. 19810 |
| Location | , Cuba |
| Coordinates | 23.0731°N 82.4576°W / 23.0731; -82.4576][[Category:Pages using gadget WikiMiniAtlas]]"},"html":"Coordinates: </templatestyles>\"}' data-mw='{\"name\":\"templatestyles\",\"attrs\":{\"src\":\"Module:Coordinates/styles.css\"},\"body\":{\"extsrc\":\"\"}}'/>23°04′23″N 82°27′27″W / 23.0731°N 82.4576°W"}"> |
 | |
| Website | www |
In response to fight against COVID-19, Finlay Institute has developed the Soberana 02.[3] In March 2021, Vicente Vérez, director of the Finlay Institute, announced a delay in the development of vaccines and indicated the start of vaccination of the Cuban population in July 2021.[4]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.